Network origin in Emily Lee Kelley first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Emily Lee Kelley via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Director of Finance/CFO | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Founder | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Quadriga BioSciences, Inc.
 Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Wisconsin | College/University | Doctorate Degree Doctorate Degree | |
| XENOPORT, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| Auckland University | College/University | Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Rubedo Life Sciences, Inc.
 Rubedo Life Sciences, Inc. Packaged SoftwareTechnology Services Rubedo Life Sciences, Inc. develops intelligent drug platform to design unique, targeted and controlled therapies for age-related diseases. The company was founded by Marco Quarta, Mark Gallop and Julian Klein in 2018 and is headquartered in Silicon Valley, CA. | Packaged Software | Founder | |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co. LLC is a venture capital firm founded by Lawrence Miller and Paul Howard in 1999. It is headquartered in Newton, Massachusetts. | Investment Managers | Chairman | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Founder | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree | |
| Zoecon Corp. | Corporate Officer/Principal | ||
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of California | College/University | Undergraduate Degree | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Oxonica Ltd.
 Oxonica Ltd. Miscellaneous Commercial ServicesCommercial Services Oxonica Ltd. is an advanced materials business, which engages in licensing of patents related to nanomaterials. The company was founded in 1999 and is headquartered in Birmingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| University of California, Santa Cruz | College/University | Undergraduate Degree | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Alavita Pharmaceuticals, Inc.
 Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alavita Pharmaceuticals, Inc. develops pharmaceutical therapeutic products. The company was founded on October 9, 2007 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Protein Metrics, Inc.
 Protein Metrics, Inc. Information Technology ServicesTechnology Services Part of Insightful Science Holdings LLC, Protein Metrics, Inc. is a company that specializes in protein characterization. The company is based in Cupertino, CA at the crossroads of computing and biotechnology. The company's vendor-neutral software enables scientists to quickly identify and report protein sequences and variations from the expected form using data generated on analytical instruments like mass spectrometers. The company was founded by Yong Kil, Marshall Bern, Chris Becker, and Eric Carlson has been the CEO of the company since 2014. Protein Metrics was acquired by Insightful Science Holdings LLC on December 21, 2021. | Information Technology Services | Director/Board Member | |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
| APEXIGEN, INC. | Biotechnology | Director/Board Member | |
Okava Pharmaceuticals, Inc.
 Okava Pharmaceuticals, Inc. BiotechnologyHealth Technology Okava Pharmaceuticals, Inc. is an American clinical stage biotechnology company. | Biotechnology | Director/Board Member | |
| California Polytechnic State University (San Luis Obispo) | College/University | Undergraduate Degree | |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director of Finance/CFO |
Statistics
International
| United States | 41 |
| United Kingdom | 3 |
| Taiwan | 2 |
| New Zealand | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Technology Services | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 19 |
| Corporate Officer/Principal | 16 |
| Chief Tech/Sci/R&D Officer | 8 |
| Founder | 7 |
| Independent Dir/Board Member | 7 |
Most connected contacts
| Insiders | |
|---|---|
| Gordon Ringold | 20 |
| Eric M. Gordon | 10 |
| Ronald Barrett | 9 |
| Mark A. Gallop | 7 |
| Larry Mattheakis | 7 |
| Gail A. Sloan | 5 |
| Richard J. Anderson | 5 |
- Stock Market
- Insiders
- Emily Lee Kelley
- Company connections